Low Dosage Hydrate Inhibitors - Global Market Outlook (2015-2022)
According to Stratistics MRC, the Low Dosage Hydrate Inhibitors Market is valued at $XX billion in 2015 and is projected to reach $XX billion by 2022 growing at a CAGR of XX% from 2015 to 2022. Increasing research applications and growing demand for high consumption of crude oil are some of the key factors driving the market growth. Population growth and industrialization are some of the key drivers in this market growth. Furthermore, growing population and rapid industrialization generate an increase in demand of energy. Increasing energy demand leads to higher production of oil which in turn, leads to the growth of low dosage hydrate inhibitors. However, cost effective, continuous fabrication of crude oil and low dosage hydrate inhibitor usage are the restraints hampering this market growth. North American region is expected to register a significant growth for these products over the forecast period.
Some of the key players in the market include Ashland, Halliburton and NALCO (ECOLAB COMPANY), NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Maris LLC, LEWA ,Woodview Technology and BASF.
Basis Covered:
Some of the key players in the market include Ashland, Halliburton and NALCO (ECOLAB COMPANY), NEFTECHIM Technologies, JSC Gazprom Neftekhim Salavat, Clariant Chemicals, GasHydrate LLC, Evonik, Ecolab, ClariantOilServices, Yara International, Stella Maris LLC, LEWA ,Woodview Technology and BASF.
Basis Covered:
- Anti-Agglomerate (AA) inhibitors
- Kinetic Hydrate Inhibitors (KHI)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL LOW DOSAGE HYDRATE INHIBITORS MARKET, BY BASIS
5.1 Introduction
5.2 Anti-Agglomerate (AA) inhibitors
5.3 Kinetic Hydrate Inhibitors (KHI)
6 GLOBAL LOW DOSAGE HYDRATE INHIBITORS MARKET, BY GEOGRAPHY
6.1 North America
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia Pacific
6.4 Rest of the World
6.4.1 Middle East
6.4.2 Brazil
6.4.3 Argentina
6.4.4 South Africa
6.4.5 Egypt
7 KEY DEVELOPMENTS
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
8 COMPANY PROFILING
8.1 Ashland
8.2 Halliburton
8.3 NALCO (ECOLAB COMPANY)
8.4 Woodview Technology
8.5 BASF
8.6 NEFTECHIM Technologies
8.7 JSC Gazprom Neftekhim Salavat
8.8 Clariant Chemicals
8.9 GasHydrate LLC
8.10 Evonik
8.11 Ecolab
8.12 ClariantOilServices
8.13 Yara International
8.14 Stella Maris LLC
8.15 LEWA
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL LOW DOSAGE HYDRATE INHIBITORS MARKET, BY BASIS
5.1 Introduction
5.2 Anti-Agglomerate (AA) inhibitors
5.3 Kinetic Hydrate Inhibitors (KHI)
6 GLOBAL LOW DOSAGE HYDRATE INHIBITORS MARKET, BY GEOGRAPHY
6.1 North America
6.1.1 US
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 New Zealand
6.3.6 Rest of Asia Pacific
6.4 Rest of the World
6.4.1 Middle East
6.4.2 Brazil
6.4.3 Argentina
6.4.4 South Africa
6.4.5 Egypt
7 KEY DEVELOPMENTS
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
8 COMPANY PROFILING
8.1 Ashland
8.2 Halliburton
8.3 NALCO (ECOLAB COMPANY)
8.4 Woodview Technology
8.5 BASF
8.6 NEFTECHIM Technologies
8.7 JSC Gazprom Neftekhim Salavat
8.8 Clariant Chemicals
8.9 GasHydrate LLC
8.10 Evonik
8.11 Ecolab
8.12 ClariantOilServices
8.13 Yara International
8.14 Stella Maris LLC
8.15 LEWA
LIST OF TABLES
Global Low Dosage Hydrate Inhibitors Market Outlook, By Region (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
North America Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
North America Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
North America Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Europe Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Europe Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Europe Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Region (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Global Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
North America Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
North America Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
North America Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Europe Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Europe Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Europe Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Asia pacific Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Basis (201-2022) ($MN)
Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Anti-Agglomerate (AA) inhibitors (201-2022) ($MN)
Rest of the world Low Dosage Hydrate Inhibitors Market Outlook, By Kinetic Hydrate Inhibitors (KHI) (201-2022) ($MN)
